Page last updated: 2024-10-31

metoprolol and Hemorrhage

metoprolol has been researched along with Hemorrhage in 5 studies

Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.

Hemorrhage: Bleeding or escape of blood from a vessel.

Research Excerpts

ExcerptRelevanceReference
"Beta-blockers have many different physiologic effects that could potentially influence the risk of hemorrhagic events in chronic heart failure patients (CHF) on warfarin."7.73Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. ( Berlowitz, DR; Cunningham, F; Gomez-Caminero, A; Miller, DR; Oliveria, SA; Rothendler, JA, 2006)
"Beta-blockers have many different physiologic effects that could potentially influence the risk of hemorrhagic events in chronic heart failure patients (CHF) on warfarin."3.73Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin. ( Berlowitz, DR; Cunningham, F; Gomez-Caminero, A; Miller, DR; Oliveria, SA; Rothendler, JA, 2006)
"Asymptomatic carotid stenosis is when this narrowing occurs in people without a history or symptoms of this disease."3.01Pharmacological interventions for asymptomatic carotid stenosis. ( Cassola, N; Clezar, CN; Flumignan, CD; Flumignan, RL; Nakano, LC; Trevisani, VF, 2023)
"Metoprolol was given by mouth on two occasions in the 10-12 h before operation."2.66Metoprolol decreases the amount of halothane required to induce hypotension during general anaesthesia. ( Christensen, B; Grabe, N; Jakobsen, CJ, 1986)
"Many of the arrhythmias other than ventricular fibrillation had little hemodynamic consequence and did not require treatment."1.28Associated reactions during and immediately after rtPA infusion. ( Linnik, W; Ramos, R; Tintinalli, JE, 1989)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Clezar, CN1
Flumignan, CD1
Cassola, N1
Nakano, LC1
Trevisani, VF1
Flumignan, RL1
Berlowitz, DR1
Miller, DR1
Oliveria, SA1
Cunningham, F1
Gomez-Caminero, A1
Rothendler, JA1
Bovill, EG1
Terrin, ML1
Stump, DC1
Berke, AD1
Frederick, M1
Collen, D1
Feit, F1
Gore, JM1
Hillis, LD1
Lambrew, CT1
Linnik, W1
Tintinalli, JE1
Ramos, R1
Jakobsen, CJ1
Grabe, N1
Christensen, B1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00000505]Phase 30 participants Interventional1983-04-30Completed
Patients Presenting With Acute STEMI Treated With Primary PCI : Comparison of the Impact of the MIMI Approach With a Conventional Strategy of Immediate Stenting[NCT01360242]Phase 3160 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for metoprolol and Hemorrhage

ArticleYear
Pharmacological interventions for asymptomatic carotid stenosis.
    The Cochrane database of systematic reviews, 2023, 08-04, Volume: 8

    Topics: Aspirin; Atherosclerosis; Atorvastatin; Carotid Stenosis; Chlorthalidone; Fluvastatin; Hemorrhage; H

2023

Trials

2 trials available for metoprolol and Hemorrhage

ArticleYear
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Annals of internal medicine, 1991, Aug-15, Volume: 115, Issue:4

    Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Dru

1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Annals of internal medicine, 1991, Aug-15, Volume: 115, Issue:4

    Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Dru

1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Annals of internal medicine, 1991, Aug-15, Volume: 115, Issue:4

    Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Dru

1991
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Annals of internal medicine, 1991, Aug-15, Volume: 115, Issue:4

    Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Drug Administration Schedule; Dru

1991
Metoprolol decreases the amount of halothane required to induce hypotension during general anaesthesia.
    British journal of anaesthesia, 1986, Volume: 58, Issue:3

    Topics: Adult; Anesthesia Recovery Period; Anesthesia, Inhalation; Clinical Trials as Topic; Double-Blind Me

1986

Other Studies

2 other studies available for metoprolol and Hemorrhage

ArticleYear
Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.
    Pharmacoepidemiology and drug safety, 2006, Volume: 15, Issue:11

    Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atenolol

2006
Associated reactions during and immediately after rtPA infusion.
    Annals of emergency medicine, 1989, Volume: 18, Issue:3

    Topics: Arrhythmias, Cardiac; Drug Hypersensitivity; Drug Therapy, Combination; Emergencies; Hemorrhage; Hum

1989